electroCore, Inc. Q3 2025 Earnings Recap

ECOR Q3 2025 November 7, 2025

Get alerts when ECOR reports next quarter

electroCore's Q3 2025 results reflect a strategic pivot aimed at accelerating growth through key investments and acquisitions, despite a temporary delay in profitability.

Earnings Per Share Miss

$-0.40 vs $-0.36 est.

-11.1% surprise

Revenue Beat

8689000 vs 7915600 est.

+9.8% surprise

Market Reaction

1-Day -0.17%

5-Day +3.77%

30-Day -18.66%

See ECOR alongside your other holdings

Add to your portfolio — free

Key Takeaways

Delivered robust revenue growth in the VA channel, secured a new 5-year contract, and expanded sales capabilities.
Acquired NeuroMetrix's Quell portfolio, enhancing product offerings and diversifying revenue streams with a new FDA-cleared device for fibromyalgia.
Initiated targeted investments in technology and personnel to support growth in both medical and wellness divisions, positioning the company for future success.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit ECOR on AllInvestView.